|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Hormone contraception: liver function and other biochemical studies. |
| In: Hoffman, F., ed. Advanced concepts in contraception: (Proceedings of four |
| symposia, Los Angeles, Philadelphia, New York, Boston.) New York, Excerpta |
| Medica Foundation, 1968. p.14-15 |
| Of a number of biochemical tests performed on a large number of patients, both before and after taking hormonal |
| contraceptives, only the liver function tests showed abnormal results. 2.3% of control patients had abnormal |
| standard sulfobromophthalein tests. Of 711 patients treated with hormonal contraceptives 6.8% showed abnormal |
| retention of the dye. Subsequent tests on those showing dye retention were normal. These patients were free of |
| clinical evidence of liver disease. It was noted that the dose of sulfobromophthalein had been based on the weight |
| of the patient and those showing retention were mostly obese. It has been shown by others that excessive steroids |
| in the blood interfere with the function of the liver to remove the dye. The majority of abnormal tests had occurred |
| during the latter part of the menstrual cycle and extended into menstruation. Patients who had taken 10 mg of |
| Norethisterone for 5 years had a 20% incidence of abnormal tests. After 3 more years of the same therapy the results |
| were the same. Reducing the dose to 1 mg diminished the percentage of abnormal dye retention tests gradually to |
| 5% in 6 months. Therefore true liver damage was not considered present. It can be predicted that obese patients |
| are the ones most likely to have abnormal sulfobromophthalein retention tests during the luteal period of the cycle |
| when increased steroids are normally present in the blood stream. After the early phases of hormonal treatment |
| some kind of adaptation phenomenon may occur. (PubHealth.info Document ID: CONT9T 1081-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Hormone contraception: liver function and other |
| biochemical studies.", is(are) Allan JS. The source of this article is "In: Hoffman, F., ed. Advanced concepts in |
| contraception: (Proceedings of four symposia, Los Angeles, Philadelphia, New York, Boston.) New York, Excerpta |
| Medica Foundation, 1968. p.14-15". This article was published in 1968 in English language(s). (PubHealth.info® |
| Document ID: CONT9T 1081-06. All rights reserved with PubHealth.info) PIN: 41081 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |